Machida, Japan

Atsuhiro Hasegawa

This inventor holds 3 USPTO granted patents. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1997-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsuhiro Hasegawa. Retrieved from https://idiyas.com/inventor/atsuhiro-hasegawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Tokyo, JP (2003)
  • Machida, JP (1997 - 2004)

Company Filing History:


Years Active: 1997-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Atsuhiro Hasegawa: Innovator in Pyrroloquinoline Derivatives

Introduction

Atsuhiro Hasegawa is a notable inventor based in Machida, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pyrroloquinoline derivatives. With a total of 3 patents to his name, Hasegawa continues to push the boundaries of innovation in his area of expertise.

Latest Patents

Hasegawa's latest patents include the LK6-A derivatives, which focus on pyrrolo [4,3,2-de] quinoline derivatives. These innovations are expected to have a substantial impact on various applications in the pharmaceutical industry.

Career Highlights

Hasegawa is currently employed at Kyowa Hakko Kogyo Co., Ltd., a company known for its commitment to research and development in biotechnology and pharmaceuticals. His work at this esteemed organization has allowed him to explore new frontiers in chemical research.

Collaborations

Throughout his career, Hasegawa has collaborated with talented individuals such as Tsutomu Akama and Hiroyuki Nagata. These partnerships have fostered a creative environment that has led to groundbreaking discoveries.

Conclusion

Atsuhiro Hasegawa is a distinguished inventor whose work in pyrroloquinoline derivatives showcases his dedication to innovation. His contributions to the field continue to inspire future advancements in chemistry and pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…